These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 10933730)

  • 1. The mouse mammary tumor virus transcription enhancers for hematopoietic progenitor and mammary gland cells share functional elements.
    Reuss FU; Coffin JM
    J Virol; 2000 Sep; 74(17):8183-7. PubMed ID: 10933730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mouse mammary tumor virus superantigen expression is reduced by glucocorticoid treatment.
    Tovar Sepúlveda VA; Berdel B; Coffin JM; Reuss FU
    Virology; 2000 Sep; 275(1):98-106. PubMed ID: 11017791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stimulation of mouse mammary tumor virus superantigen expression by an intragenic enhancer.
    Reuss FU; Coffin JM
    Proc Natl Acad Sci U S A; 1995 Sep; 92(20):9293-7. PubMed ID: 7568120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mouse mammary tumor virus superantigen expression in B cells is regulated by a central enhancer within the pol gene.
    Reuss FU; Coffin JM
    J Virol; 1998 Jul; 72(7):6073-82. PubMed ID: 9621071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CDP binding to multiple sites in the mouse mammary tumor virus long terminal repeat suppresses basal and glucocorticoid-induced transcription.
    Zhu Q; Dudley JP
    J Virol; 2002 Mar; 76(5):2168-79. PubMed ID: 11836394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A redundant nuclear protein binding site contributes to negative regulation of the mouse mammary tumor virus long terminal repeat.
    Bramblett D; Hsu CL; Lozano M; Earnest K; Fabritius C; Dudley J
    J Virol; 1995 Dec; 69(12):7868-76. PubMed ID: 7494299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CDP is a repressor of mouse mammary tumor virus expression in the mammary gland.
    Zhu Q; Gregg K; Lozano M; Liu J; Dudley JP
    J Virol; 2000 Jul; 74(14):6348-57. PubMed ID: 10864645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of the mouse mammary tumor virus long terminal repeat open reading frame promotes tumorigenic potential of hyperplastic mouse mammary epithelial cells.
    Mukhopadhyay R; Medina D; Butel JS
    Virology; 1995 Aug; 211(1):74-93. PubMed ID: 7645239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mammary gland expression of mouse mammary tumor virus is regulated by a novel element in the long terminal repeat.
    Qin W; Golovkina TV; Peng T; Nepomnaschy I; Buggiano V; Piazzon I; Ross SR
    J Virol; 1999 Jan; 73(1):368-76. PubMed ID: 9847341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A mammary cell-specific enhancer in mouse mammary tumor virus DNA is composed of multiple regulatory elements including binding sites for CTF/NFI and a novel transcription factor, mammary cell-activating factor.
    Mink S; Härtig E; Jennewein P; Doppler W; Cato AC
    Mol Cell Biol; 1992 Nov; 12(11):4906-18. PubMed ID: 1328867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mouse mammary tumor virus sequences responsible for activating cellular oncogenes.
    Grimm SL; Nordeen SK
    J Virol; 1998 Dec; 72(12):9428-35. PubMed ID: 9811675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The 5' enhancer of the mouse mammary tumor virus long terminal repeat contains a functional AP-2 element.
    Mellentin-Michelotti J; John S; Pennie WD; Williams T; Hager GL
    J Biol Chem; 1994 Dec; 269(50):31983-90. PubMed ID: 7989375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strain-specific expression of spliced MMTV RNAs containing the superantigen gene.
    Xu L; Wrona TJ; Dudley JP
    Virology; 1997 Sep; 236(1):54-65. PubMed ID: 9299617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A mouse mammary tumor virus-like long terminal repeat superantigen in human breast cancer.
    Wang Y; Jiang JD; Xu D; Li Y; Qu C; Holland JF; Pogo BG
    Cancer Res; 2004 Jun; 64(12):4105-11. PubMed ID: 15205319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extra mouse mammary tumor proviruses in DBA/2 mouse lymphomas acquire a selective advantage in lymphocytes by alteration in the U3 region of the long terminal repeat.
    Yanagawa S; Murakami A; Tanaka H
    J Virol; 1990 Jun; 64(6):2474-83. PubMed ID: 2159524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A mouse mammary tumor virus mammary gland enhancer confers tissue-specific but not lactation-dependent expression in transgenic mice.
    Mok E; Golovkina TV; Ross SR
    J Virol; 1992 Dec; 66(12):7529-32. PubMed ID: 1331537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Type B leukemogenic virus has a T-cell-specific enhancer that binds AML-1.
    Mertz JA; Mustafa F; Meyers S; Dudley JP
    J Virol; 2001 Mar; 75(5):2174-84. PubMed ID: 11160721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endogenous superantigen expression controlled by a novel promoter in the MMTV long terminal repeat.
    Günzburg WH; Heinemann F; Wintersperger S; Miethke T; Wagner H; Erfle V; Salmons B
    Nature; 1993 Jul; 364(6433):154-8. PubMed ID: 8391646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. B and T cells are required for mouse mammary tumor virus spread within the mammary gland.
    Golovkina TV; Dudley JP; Ross SR
    J Immunol; 1998 Sep; 161(5):2375-82. PubMed ID: 9725233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Promoter complex in the central part of the mouse mammary tumor virus long terminal repeat.
    Rouault F; Nejad Asl SB; Rungaldier S; Fuchs E; Salmons B; Günzburg WH
    J Virol; 2007 Nov; 81(22):12572-81. PubMed ID: 17686873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.